P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Patients with adrenal insufficiency, genital anomalies and bony malformations resembling the Antley- Bixler syndrome (a craniosynostosis syndrome), are likely to have P450 oxidoreductase (POR) deficiency. Since our first report in 2004, about 26 recessive POR mutations have been identified in 50 patients. POR is the obligate electron donor to all microsomal (type II) P450 enzymes, including the steroidogenic enzymes CYP17A1, CYP21A2 and CYP19A1. POR deficiency may cause disordered sexual development manifested as genital undervirilization in 46,XY newborns as well as overvirilization in those who are 46,XX. This may be explained by impaired aromatization of fetal androgens which may also lead to maternal virilization and low urinary estriol levels during pregnancy. A role for the alternate 'backdoor' pathway of androgen biosynthesis, leading to dihydrotestosterone production bypassing androstenedione and testosterone, has been suggested in POR deficiency but remains unclear. POR variants may play an important role in drug metabolism, as most drugs are metabolized by hepatic microsomal P450 enzymes. However, functional assays studying the effects of specific POR mutations on steroidogenesis showed that several POR variants impaired CYP17A1, CYP21A2 and CYP19A1 activities to different degrees, indicating that each POR variant must be studied separately for each potential target P450 enzyme. Thus, the impact of POR mutations on drug metabolism by hepatic P450s requires further investigation.
Flück
Christa E
CE
Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics, University of Bern, Bern, Switzerland.
Pandey
Amit V
AV
Huang
Ningwu
N
Agrawal
Vishal
V
Miller
Walter L
WL
D000015:Abnormalities, Multiple / Q000235:genetics; D000312:Adrenal Hyperplasia, Congenital / Q000209:etiology* / Q000235:genetics; D001848:Bone Diseases, Developmental / Q000235:genetics; D001842:Bone and Bones / Q000002:abnormalities; D004579:Electron Transport / Q000235:genetics; D005838:Genotype; D006801:Humans; D008099:Liver / Q000201:enzymology; D008954:Models, Biological; D008958:Models, Molecular; D009154:Mutation / Q000502:physiology; D009251:NADPH-Ferrihemoprotein Reductase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D010641:Phenotype; D013256:Steroids / Q000096:biosynthesis; D013577:Syndrome
D013256:Steroids; D009251:NADPH-Ferrihemoprotein Reductase